| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $21.0M | +55.5% |
| R&D Expense | $88.2M | +47.4% |
| SG&A Expense | $26.4M | +29.5% |
| Operating Income | -$93.5M | -40.3% |
| Interest Expense | $3.8M | +219.6% |
| Net Income | -$89.2M | -34.7% |
| EPS (Basic) | -$1.36 | +50.5% |
| EPS (Diluted) | -$1.36 | +50.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $133.4M | +11.1% |
| Short-term Investments | $58.7M | — |
| Current Assets | $194.2M | +56.5% |
| Total Assets | $272.1M | +36.7% |
| Current Liabilities | $29.8M | +72.3% |
| Long-term Debt | $30.0M | +2.6% |
| Total Liabilities | $121.3M | +21.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.4M | +7.7% |
| Capital Expenditures | $3.1M | -25.5% |
| Investing Cash Flow | -$60.8M | -1338.1% |
| Financing Cash Flow | $135.4M | +361.4% |
| Free Cash Flow | -$64.5M | +8.8% |
| Stockholders' Equity |
| $150.9M |
| +51.7% |